Duopharma Biotech (Malaysia) Market Value
| 7148 Stock | 1.25 0.01 0.81% |
| Symbol | Duopharma |
Duopharma Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Duopharma Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Duopharma Biotech.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Duopharma Biotech on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Duopharma Biotech Bhd or generate 0.0% return on investment in Duopharma Biotech over 510 days. Duopharma Biotech is related to or competes with Sports Toto, Petronas Chemicals, Carlsberg Brewery, and K One. More
Duopharma Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Duopharma Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Duopharma Biotech Bhd upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.81 | |||
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 9.73 | |||
| Value At Risk | (2.52) | |||
| Potential Upside | 2.56 |
Duopharma Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Duopharma Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Duopharma Biotech's standard deviation. In reality, there are many statistical measures that can use Duopharma Biotech historical prices to predict the future Duopharma Biotech's volatility.| Risk Adjusted Performance | 0.0228 | |||
| Jensen Alpha | 0.043 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | (0.21) |
Duopharma Biotech Bhd Backtested Returns
As of now, Duopharma Stock is very risky. Duopharma Biotech Bhd secures Sharpe Ratio (or Efficiency) of 0.0391, which denotes the company had a 0.0391% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Duopharma Biotech Bhd, which you can use to evaluate the volatility of the firm. Please confirm Duopharma Biotech's Downside Deviation of 1.81, coefficient of variation of 4362.49, and Mean Deviation of 1.07 to check if the risk estimate we provide is consistent with the expected return of 0.0651%. Duopharma Biotech has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.13, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Duopharma Biotech are expected to decrease at a much lower rate. During the bear market, Duopharma Biotech is likely to outperform the market. Duopharma Biotech Bhd right now shows a risk of 1.66%. Please confirm Duopharma Biotech Bhd jensen alpha, sortino ratio, and the relationship between the standard deviation and total risk alpha , to decide if Duopharma Biotech Bhd will be following its price patterns.
Auto-correlation | 0.05 |
Virtually no predictability
Duopharma Biotech Bhd has virtually no predictability. Overlapping area represents the amount of predictability between Duopharma Biotech time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Duopharma Biotech Bhd price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Duopharma Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Duopharma Biotech Bhd lagged returns against current returns
Autocorrelation, which is Duopharma Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Duopharma Biotech's stock expected returns. We can calculate the autocorrelation of Duopharma Biotech returns to help us make a trade decision. For example, suppose you find that Duopharma Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Duopharma Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Duopharma Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Duopharma Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Duopharma Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Duopharma Biotech Lagged Returns
When evaluating Duopharma Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Duopharma Biotech stock have on its future price. Duopharma Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Duopharma Biotech autocorrelation shows the relationship between Duopharma Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Duopharma Biotech Bhd.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Duopharma Stock
Duopharma Biotech financial ratios help investors to determine whether Duopharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Duopharma with respect to the benefits of owning Duopharma Biotech security.